After weight loss, Alzheimer’s may be next frontier for drugs like Ozempic

By Natalie Grover LONDON (Reuters) – Diabetes drugs that also promote weight loss such as Novo Nordisk’s Ozempic, becoming a darling of celebrities and investors, are being studied to tackle some of the most difficult-to-treat brain disorders, including Alzheimer’s disease. Diabetes regimens, from Ozempic to old mainstays like insulin and metformin, appear to address several…

Read More

First-time voters may have decisive say in Turkish election

By Birsen Altayli and Ezgi Erkoyun ISTANBUL (Reuters) – Turkish university student Yunus Efe has known only one leader of his country – Tayyip Erdogan. As he prepares to vote for the first time in elections this month, the 22-year-old says it is time for change. Efe is one of more than 6 million first-time…

Read More